Brand-name · Dual GLP-1 / GIP receptor agonist (tirzepatide)

Zepbound®

Zepbound® (tirzepatide) once-weekly injection. FDA-approved for chronic weight management and for moderate-to-severe obstructive sleep apnea in adults with obesity.

Starting at$449.99/mo

Check If I Qualify Read the FAQs

Form

Pre-filled injection pen

Frequency

Once weekly

Drug class

Dual GLP-1 / GIP receptor agonist (tirzepatide)

Who is a candidate for this medication?

Adults 18+ with BMI 30+, or 27+ with a weight-related condition.
Want the FDA-approved brand version of tirzepatide.
Comfortable with a once-weekly self-injection.

Who this medication is not for

Personal or family history of medullary thyroid cancer or MEN 2.
Pregnancy, planning pregnancy, or breastfeeding.
History of pancreatitis or severe GI disorders.

Dosage overview

Phase	Dose
Weeks 1–4	2.5 mg once weekly (non-therapeutic starter dose).
Weeks 5+	Escalated in 2.5 mg increments no faster than every 4 weeks, up to 15 mg.

Side effects to know about

Common

· Nausea
· Diarrhea
· Vomiting
· Constipation
· Injection-site reactions

Serious (call your doctor)

· Pancreatitis
· Gallbladder disease
· Kidney injury
· Severe hypersensitivity

How your care is monitored

Monthly during titration, then quarterly at maintenance.
Renal, GI, and gallbladder symptom review at each visit.

Pricing

Zepbound® starts at $449.99/mo. No insurance required. HSA/FSA eligible. Cancel anytime.

Common questions

Is Zepbound covered by insurance?

Coverage varies by plan and indication. Many plans require prior authorization; Eli Lilly offers a savings card for eligible patients.

Ready to see if Zepbound is right for you?

Complete a 5-minute online intake. A US-licensed physician reviews your history and only prescribes if it's safe and appropriate for you.

Check If I Qualify — Free & Fast

Compare other medications

Compounded

Compounded Semaglutide

From $149.99/28-day supply

Compounded

Compounded Tirzepatide

From $249.99/28-day supply